Market Overview
Conjugated estrogen is an active pharmaceutical ingredient that contains a mixture of steroidal and non-steroidal components that are obtained from pregnant mares’ urine. Conjugated estrogen is used as an external source and is prescribed as a replacement of female natural hormones.
Estrogen has many well-known effects on the tissues of the body. It causes the growth of the inner lining of uterus, secretion of cervix, development & growth of female sexual organs and maintains the sexual characteristics of females, such as hair growth of underarm and pubic area and countering of body and bone.
Due to the low production of estrogen in the body, about 85% of women have symptoms such as hot flushes, bone loss, vaginal dryness and shrinkage of tissues.
For these symptoms, menopause hormone treatment therapy is the most effective treatment. Conjugated estrogen helps menopausal women treat symptoms such as shrinkage of vaginal tissue, vaginal dryness, hot flashes, bone loss and painful intercourse.
Conjugated Estrogen Market: Drivers
Menopause is a natural and normal process in women, which occurs due to aging and lowers the function of ovaries and lowers the levels of estrogen and other hormones in the body.
The growing prevalence of the female geriatric population and women with menopause is the major factor driving the growth of the conjugated estrogens market over the forecast period.
However, limited awareness and negligence about women healthcare services in developing nations and related side effects among women due to menopause hormone treatment therapy are restraining the revenue growth of the global conjugated estrogen market.
To Remain ‘Ahead’ Of Your Competitors, Request For Brochure https://www.factmr.com/connectus/sample?flag=B&rep_id=2289
Conjugated Estrogen Market: Segmentation
The global conjugated estrogen market can be segmented on the basis of form, route of administration, end user and geography.
Based on form, the global conjugated estrogen market has been segmented as:
Tablets
Creams
Powder
Vials
Based on route of administration, the global conjugated estrogen market has been segmented as:
Oral
Topical
Injection
Based on end user, the global conjugated estrogen market has been segmented as:
Hospitals
Obstetrics & Gynecology Clinics
Others
Based on geography, the global conjugated estrogen market has been segmented as:
North America
Latin America
Europe
Asia-Pacific excluding Japan (APEJ)
Japan
Middle East & Africa (MEA)
Important doubts related to the Conjugated Estrogen Market clarified in the report:
Which regional market is expected to witness the highest growth during the forecast period?
How has the surging prices of raw materials during the COVID-19 pandemic impacted the growth of the market?
Why are market players focusing on R&D and innovations?
Are market players expanding their global presence? If yes, how?
Report regional analysis includes:
North America
Europe
MEA
East Asia (Japan, China, South Korea)
South Asia (India, Thailand, Malaysia, Indonesia, Philippines, Rest)
Oceania (Australia, New Zealand)
Latin America
Middle East and Africa (GCC Countries, South Africa, Turkey, Iran, Israel)
USP OF REPORT : DON’T PAY UNTIL YOU ARE SATISFIED – https://www.factmr.com/connectus/sample?flag=RC&rep_id=2289
Conjugated Estrogen Market: Market Participants
Some of the key players in the global conjugated estrogen market include Pfizer Inc., Teva Pharmaceuticals USA, Inc., Xi’an sgonek biological Technology Co., Ltd., Teva Branded Pharm and others.
Competitive landscape
Strategies of key players and Products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
Conjugated Estrogen Market: Regional Outlook
On the basis of geography, the global conjugated estrogen market has been segmented into viz. North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East & Africa (MEA).
North America is expected to be the dominant market in the global conjugated estrogen market due to growing prevalence of the geriatric female population with menopause, initiatives towards increasing female health awareness and health coverage.
Conjugated estrogen is specifically approved in the United States and Canada for menopause-related problems.
Europe is expected to register the second largest share in the global conjugated estrogen market throughout the forecast period, owing to the increasing awareness regarding female healthcare.
The conjugated estrogen market in Asia Pacific excluding Japan is expected to grow at a high CAGR due to large population growth and increasing aging population of women and large presence of local players.
Highlights from the Report
Elaborated scenario of the parent market
Transformations in the market dynamics
Detailed segmentation of the target market
Historical, current and forecast market size based on value and volume
Latest industry developments and trends
Competition landscape
Strategies adopted by the market players and product developments made
Potential and niche segments, along with their regional analysis
Unbiased analysis on performance of the market
Up-to-date and must-have intelligence for the market players to enhance and sustain their competitiveness
Why Choose Fact.MR ?
Our analysts have exceptional knowledge of the latest market research techniques
We use the latest market research and analytical tools to curate market reports
High-quality customized reports available as per the client’s requirements
Our team consists of highly experienced and trained analysts
Swift and prompt customer support for domestic and international clients
COVID-19 analysis with credible insights
Read More Trending Reports of Fact.MR : https://www.globenewswire.com/en/news-release/2020/03/05/1995851/0/en/Consumption-of-Pine-Chemicals-Projected-to-Soar-at-over-5-CAGR-Through-2027-Bio-friendly-Products-to-Steal-the-Limelight-Says-a-Fact-MR-Report.html
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: [email protected]
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Website : https://www.factmr.com/
https://www.factmr.com/report/2289/conjugated-estrogen-market
|